Caffeine dose-dependently potentiates the antitumor effect of cisplatin on osteosarcomas

Anticancer Research

Volumn 28, Issue 3 A, 2008, Pages 1681-1685

  Kawahara, Masami ^a   Takahashi, Yuri ^a   Takazawa, Kotaro ^a   Tsuchiya, Hiroyuki ^a   Tomita, Katsuro ^a   Yokogawa, Koichi ^a   Miyamoto, Ken Ichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Caffeine; Cisplatin; Combination therapy; Osteosarcoma

Indexed keywords

CAFFEINE; CARCINOGEN; CISPLATIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG POTENTIATION; MALE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CAFFEINE; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; MALE; OSTEOSARCOMA; RATS; RATS, INBRED F344; TISSUE DISTRIBUTION;

EID: 45949097135     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Souhami RL, Craft AW, Van der Eijken JW et al: Randomized trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 350: 911-917, 1997.
2. Harris MB, Giese P, Goorin AM et al: Treatment of metastatic osteosarcoma at diagnosis: a pediatric oncology group study. J Clin Oncol 16: 3641-3648, 1998.
3. Tsuchiya H, Yasutake H, Yokogawa A et al: Effect of chemotherapy combined with caffeine for osteosarcoma. J Cancer Res Clin Oncol 118: 567-569, 1992.
4. Tsuchiya H, Tomita K, Mori Y et al: Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma. Anticancer Res 18: 657-666, 1998.
5. Van Den Berg HW and Roberts JJ: Post-replication repair of DNA in Chinese hamster cells treated with cis platinum (II) diamine dichloride. Enhancement of toxicity and chromosome damage by caffeine. Mutat. Res 33: 279-284, 1975.
6. Takahashi M, Yanoma S, Yamamoto Y et al: Combined effect of CDDP and caffeine against human gastric cell line in vivo. Anticancer Res 18(6A): 4399-4401, 1998.
7. Fingert HJ, Pu AT, Chen Z et al: In vivo and in vitro enhanced antitumor effects by pentoxifylline in human cancer cells treated with thiotepa. Cancer Res 48: 4375-4381, 1988.
8. Tomita K and Tsuchiya H: Caffeine enhancement of the effect of anticancer agents on human sarcoma cells. Jpn J Cancer Res 80: 83-88, 1989.
9. Petru E, Boike G and Sevin BU: Potentiation of cisplatin cytotoxicity by methylxanthines in vitro. J Cancer Res Clin Oncol 116: 431-433, 1990.
10. Kawahara M, Kagiyama H, Kanazawa Y et al: Rapid determination method of caffeine and application to monitoring of caffeine-assisted chemotherapy. Biophrm Drug Dispos 25: 61-67, 2004.
11. Mii Y, Tsutsumi M, Shiraiwa K et al: Transplantable osteosarcomas with high lung metastatic potential in Fischer 344 rats. Jpn J Cancer Res 79: 589-592, 1988.
12. Honoki K, Mori T, Tsutsumi M et al: Heterogeneous pattern of gene expression in cloned cell lines established from a rat transplantable osteosarcoma lung metastatic nodule. Cancer Lett 127: 221-228, 1998.
13. Kido A, Tsutsumi M, Iki K et al: Overexpression of matrix metalloproteinase (MMP)-9 correlates with metastatic potency of spontaneous and 4-hydroxyaminoquinoline 1-oxide (4-HAQO)-induced transplantable osteosarcomas in rats. Cancer Lett 137: 209-216, 1999.
14. Bode AM and Dong Z: The enigmatic effects of caffeine in cell cycle and cancer. Cancer Lett 247: 26-39, 2007.
15. Gabrielli B, Chau YQ, Giles N et al: Caffeine promotes apoptosis in mitotic spindle checkpoint-arrested cells. J Biol Chem 282: 6954-6964, 2007.
16. Sadzuka Y, Mochizuki E and Takino T: Mechanism of caffeine modulation of the antitumor activity of adriamycin. Toxicol Let 75: 39-49, 1995.
17. Kawai H, Kiura K, Tabata M et al: Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy. Lung Cancer 35: 305-314, 2002.